Abstract
The genetic material in humans contains approximately 6 billion base pairs in the nuclear genome and 16,569 base pairs in the mitochondrial genome [1-3]. In some cases the difference between a healthy and a sick individual consists in only one nucleotide. Thus, it is evident that the pristine replication of the genome is a key event in the avoidance of mutations and therefore diseases. Although it is generally believed that DNA is an inert molecule, it contains reactive groups that are exposed to a multitude of chemical agents like Reactive Oxidative Species (ROS), xenobiotic compounds, and UV light which can react with DNA to form adducts that compromise its coding potential. For instance, it is estimated that a mammalian genome suffers close to 100,000 abasic sites per day [4, 5]. In general, replicative DNA polymerases are responsible for maintaining the integrity of the genome during it replication, family X polymerases are important in DNA repair mechanisms, and Translesion Synthesis DNA polymerases ensure the faithful replication across from DNA lesions. This revision attempts to briefly summarize the role of human template dependent DNA polymerases involved in replication, DNA repair, and lesion bypass.
Keywords: DNA polymerases, structure-function
Current Topics in Medicinal Chemistry
Title: Template Dependent Human DNA Polymerases
Volume: 8 Issue: 15
Author(s): Luis G. Brieba
Affiliation:
Keywords: DNA polymerases, structure-function
Abstract: The genetic material in humans contains approximately 6 billion base pairs in the nuclear genome and 16,569 base pairs in the mitochondrial genome [1-3]. In some cases the difference between a healthy and a sick individual consists in only one nucleotide. Thus, it is evident that the pristine replication of the genome is a key event in the avoidance of mutations and therefore diseases. Although it is generally believed that DNA is an inert molecule, it contains reactive groups that are exposed to a multitude of chemical agents like Reactive Oxidative Species (ROS), xenobiotic compounds, and UV light which can react with DNA to form adducts that compromise its coding potential. For instance, it is estimated that a mammalian genome suffers close to 100,000 abasic sites per day [4, 5]. In general, replicative DNA polymerases are responsible for maintaining the integrity of the genome during it replication, family X polymerases are important in DNA repair mechanisms, and Translesion Synthesis DNA polymerases ensure the faithful replication across from DNA lesions. This revision attempts to briefly summarize the role of human template dependent DNA polymerases involved in replication, DNA repair, and lesion bypass.
Export Options
About this article
Cite this article as:
Brieba G. Luis, Template Dependent Human DNA Polymerases, Current Topics in Medicinal Chemistry 2008; 8 (15) . https://dx.doi.org/10.2174/156802608786141098
DOI https://dx.doi.org/10.2174/156802608786141098 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease
Current Neuropharmacology Current Perspectives of Healthy Mitochondrial Function for Healthy Neurons
Current Drug Targets New Insights Emerging from Recent Investigations on Human Group II Pyridoxal 5’-Phosphate Decarboxylases
Current Medicinal Chemistry The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) GABAergic Drugs for the Treatment of Migraine
CNS & Neurological Disorders - Drug Targets Neurodegenerative Diseases of the Retina and Potential for Protection and Recovery
Current Neuropharmacology The Role of Blood-Brain Barrier Transporters in Pathophysiology and Pharmacotherapy of Stroke
Current Pharmaceutical Design Diagnostic Boundaries of Autism Disorder Vs Pervasive Developmental Disorder Nos Comparative Observational Study and Literature Review
Current Clinical Pharmacology Neuropharmacological Profile of Gamma-Decanolactone on Chemically-induced Seizure in Mice
Central Nervous System Agents in Medicinal Chemistry <i>In Silico</i> Study Examining New Phenylpropanoids Targets with Antidepressant Activity
Current Drug Targets New Targets for Therapy in Polyglutamine (polyQ) Expansion Diseases
Current Drug Therapy Editorial [Hot Topic: Drugs and Pregnancy (Guest Editor: Zaneta Kimber-Trojnar)]
Current Pharmaceutical Biotechnology New Medical Strategies for Midgut Carcinoids
Anti-Cancer Agents in Medicinal Chemistry Interactions of β - and Hydroxypropyl-β-Cyclodextrin with Some Purine Alkaloids:Thermodynamic Study
Current Drug Discovery Technologies Herbal Medicine in the Treatment of Epilepsy
Current Drug Targets Serotonin Control of Dopaminergic Neurotransmission: Focus on 5-HT2 Receptors
Current Neuropharmacology Anxiolytic-Like Effects of 7H-Benzo[e]perimidin-7-One Derivatives through Elevated Plus-Maze Test in Mice
Current Topics in Medicinal Chemistry Synthesis and First Evaluation of [<sup>18</sup>F]Fluorocyano- and [<sup>18</sup>F]Fluoronitroquinoxalinedione as Putative AMPA Receptor Antagonists
Medicinal Chemistry Measuring Receptor Occupancy with PET
Current Pharmaceutical Design GABA Puts a Stop to Pain
Current Drug Targets - CNS & Neurological Disorders